Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
100 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2022-09-22 | 2022-12-22 | 169957 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2021-03-25 | 2021-04-01 | 136300 |
| TEVA-ECTOSONE | 0.1% | CREAM | Resolved | 2020-03-19 | 2020-07-09 | 109053 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2020-03-26 | 2020-04-23 | 109601 |
| TEVA-ECTOSONE | 0.1% | CREAM | Resolved | 2022-12-22 | 2023-12-14 | 179180 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2023-04-27 | 2023-07-05 | 190689 |
| TEVA-ECTOSONE | 0.05% | CREAM | Resolved | 2023-06-08 | 2023-11-16 | 194068 |
| TEVA-ECTOSONE | 0.05% | LOTION | Resolved | 2023-06-08 | 2024-03-07 | 194074 |
| TEVA-ECTOSONE | 0.05% | LOTION | Resolved | 2023-06-16 | 2023-07-05 | 195189 |
| TEVA-ECTOSONE | 0.05% | LOTION | Actual shortage | 2024-03-28 | 2024-07-11 | 223832 |
| TEVA-ECTOSONE | 0.1% | LOTION | Actual shortage | 2024-04-25 | 2024-08-08 | 226171 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2021-07-29 | 2021-09-30 | 143242 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2021-08-27 | 2023-12-05 | 144715 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2020-09-24 | 2020-10-01 | 124953 |
| TEVA-EFAVIRENZ | 600MG | TABLET | Resolved | 2023-06-20 | 2023-07-06 | 195858 |
| TEVA-EFAVIRENZ | 600MG | TABLET | Resolved | 2023-04-27 | 2023-07-06 | 190767 |
| TEVA-EFAVIRENZ | 600MG | TABLET | Resolved | 2020-05-01 | 2020-06-11 | 113782 |
| TEVA-EFAVIRENZ | 600MG | TABLET | Resolved | 2025-01-09 | 2025-04-29 | 247357 |
| TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | 300MG 200MG 600MG | TABLET | Actual shortage | 2025-01-23 | 2025-01-23 | 248436 |
| TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | 300MG 200MG 600MG | TABLET | Resolved | 2022-06-03 | 2023-02-11 | 161940 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ENALAPRIL | 16MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64866 |
| TEVA-ENALAPRIL | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64869 |
| TEVA-FAMOTIDINE | 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81371 |
| TEVA-FINGOLIMOD | 0.5MG | CAPSULE | Discontinued | 2025-03-20 | 2025-03-20 | 253186 |
| TEVA-FLUCONAZOLE | 100MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256091 |
| TEVA-FLUCONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256137 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |